PraxisDirect 2.0 Forecasts Enrollment Success

Brentwood, TN -- September 3, 2008-- Praxis, a company specializing in centralized patient recruitment for clinical research studies, is proud to announce the release of PraxisDirect 2.0, the most advanced technology in patient recruitment management.  Hundreds of thousands of interested trial candidates, decades of clinical trial recruitment experience, input from hundreds of study coordinators, and therapeutic indications across the board came together to create the business intelligence and metrics that make up PraxisDirect 2.0.         

PraxisDirect 2.0 gives sponsors up to the minute recruitment campaign results and analyses in real time through easy-to-read charts, graphs and tables. Study coordinators and research site staff report that PraxisDirect 2.0 is helpful, and better than other systems they’ve used.  Praxis & sponsors use this technology as the go to place for in-depth study analysis.  With just a few clicks you have an accurate tally of referrals’ screened and randomized, how communication tactics are generating responses, which sites are quickly following up with referrals and much more. 

PraxisDirect 2.0 collects Praxis pre-qualified candidate data through the centralized recruitment center, as well as integrates data from sponsors IVRS/CTMS systems. Multilingual pre-screening with detailed analysis allows sponsors conducting global trials increased flexibility and ease as well. Sponsors can view how each site is performing and assess their efficiency with the new PraxisDirect 2.0 site rankings. Donna Beasley, VP of Operations and Marketing says, “We are thrilled to be releasing this latest version of PraxisDirect.  We have been listening to our clients and uncovering ways to make this dynamic technology even more useful for sponsors since the release of the program initially.  It has been a huge success as measured by the ease of use by our clients, real-time decisions we are able to make that help make the best use of our clients’ budgets and our exceptional rate of meeting and exceeding sponsor timelines of enrollment.”  Beasley also states “These enhanced features work in combination with Praxis’ results-producing creative and study management to create an unrivaled level of service and success for our clients.”

PraxisDirect 2.0 features customized homepage dashboard views – for site staff and for sponsors.  The dashboard at-a-glance charts, graphs and analyses provide the user with key results that are most important to them.  The enrollment projection indicator tells sponsors continually, by how far their studies are on track to exceed enrollment goals.  Sponsors see the immediate results of their recruitment investments.  Site performance analyses tell sponsors which sites are taking their pre-qualified referrals and converting them to screened and randomized patients most effectively.  All of which allows Praxis the ability to invest recruitment support in the site areas where the sponsor gets the best results.  Beasley states “We have always been able to monitor and make real-time decisions on support activities, but with these new enhancements to the programming, sponsors are also able to quickly see which sites are making the best use of their recruitment investment.” 

In a survey of study coordinators completing the pilot study using PraxisDirect 2.0, of those that had used some sort of enrollment management system before, 93% found the enhanced PraxisDirect 2.0 to be better than others they’ve used.  Study coordinators reported that the system was helpful and they liked how they could see where their site stood on enrollment compared to others participating.    

Praxis Communications, Inc., headquartered in Brentwood, TN, provides the pharmaceutical and biotech industries with a wide range of services for patient recruitment and retention for clinical trials including patient profiling, recruitment planning, centralized fulfillment, media relations, advertising, and program management. For more information, call Praxis at (615) 312-8207.

> Back to Press Releases